Related Experiment Videos
Novel interactions between urokinase and its receptor.
1Department of Clinical Biochemistry, Hebrew University-Hadassah Medical Centers, Jerusalem, Israel IL-91120.
The Journal of Biological Chemistry
|May 10, 2000
Summary
Novel interactions between urokinase-type plasminogen activator (uPA) and its receptor (uPAR) at high concentrations reveal new regulatory mechanisms. These findings shed light on uPA/uPAR signaling pathways and enzyme activity.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- Urokinase-type plasminogen activator (uPA) and its receptor (uPAR) form complexes with varying affinities.
- uPA/uPAR complex functions include catalytic activity and signal transduction, observed at different concentrations.
Purpose of the Study:
- To investigate novel interactions between uPA and soluble uPAR (suPAR) at supra-saturating concentrations.
- To elucidate the role of suPAR oligomerization in modulating uPA binding and activity.
Main Methods:
- Dynamic light scattering, gel filtration, and electron microscopy to analyze suPAR structure.
- Biacore assays to determine binding affinities of uPA to suPAR forms.
- Enzyme activity assays for scuPA/suPAR and tcuPA/suPAR complexes.
Main Results:
- suPAR exists in monomer, dimer, and oligomer forms.
- High concentrations of uPA and suPAR induce novel interactions, increasing complex activity.
- scuPA binding causes dissociation of suPAR dimers/oligomers, with reduced affinity for these forms compared to monomers.
- uPA binding to suPAR dimers/oligomers shows lower affinity than to monomers.
Conclusions:
- uPAR exists in an equilibrium of monomeric, dimeric, and oligomeric states.
- These novel interactions and varying affinities regulate uPA/uPAR complex activity.
- The findings suggest a new mechanism for uPA/uPAR-mediated signal transduction.